HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection.

Abstract
The present study was designed to elucidate the role of Valpha14(+) NKT cells in the host defense against pulmonary infection with Streptococcus pneumoniae using Jalpha281 gene-disrupted mice (Jalpha281KO mice) that lacked this lymphocyte subset. In these mice, pneumococcal infection was severely exacerbated, as shown by the shorter survival time and marked increase of live bacteria in the lung compared to wild-type (WT) mice. The proportion of Valpha14(+) NKT cells, detected by an alpha-galactosylceramide (alpha-GalCer)-loaded CD1d tetramer, increased in thelung after S. pneumoniae infection. This increase was significantly reduced in mice with a genetic disruption of monocyte chemotactic protein (MCP)-1, which was produced in the early phaseof infection in WT mice. In the lungs of Jalpha281KO mice, the number of neutrophils was significantly lower at 12 h than that in WT mice. In support of this finding, macrophage inflammatory protein (MIP)-2 and TNF-alpha synthesis in infected lungs was significantly reduced at 3 h and at both 3 and 6 h, respectively, in Jalpha281KO mice, compared to WT mice. In addition, treatment of mice with alpha-GalCer significantly improved the outcome of this infection. Our results demonstrated MCP-1-dependent recruitment of Valpha14(+) NKT cells and their critical role in early host protection against S. pneumoniae by promoting the trafficking of neutrophils to the site of infection.
AuthorsKazuyoshi Kawakami, Natsuo Yamamoto, Yuki Kinjo, Kazuya Miyagi, Chikara Nakasone, Kaori Uezu, Takeshi Kinjo, Toshinori Nakayama, Masaru Taniguchi, Atsushi Saito
JournalEuropean journal of immunology (Eur J Immunol) Vol. 33 Issue 12 Pg. 3322-30 (Dec 2003) ISSN: 0014-2980 [Print] Germany
PMID14635040 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation, B-Lymphocyte
  • Chemokine CCL2
  • Chemokine CXCL2
  • Chemokines
  • Cxcl2 protein, mouse
  • Galactosylceramides
  • Histocompatibility Antigens Class II
  • Receptors, Antigen, T-Cell, alpha-beta
  • Tumor Necrosis Factor-alpha
  • invariant chain
Topics
  • Animals
  • Antigens, Differentiation, B-Lymphocyte
  • Chemokine CCL2 (physiology)
  • Chemokine CXCL2
  • Chemokines (biosynthesis)
  • Galactosylceramides (pharmacology)
  • Histocompatibility Antigens Class II
  • Immunity, Innate
  • Killer Cells, Natural (immunology)
  • Lung (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Neutrophils (immunology)
  • Pneumococcal Infections (immunology)
  • Receptors, Antigen, T-Cell, alpha-beta (physiology)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: